Having COVID-19 had no clinically meaningful impact on lung function and nutritional status for people with cystic fibrosis in…
Articles by Andrea Lobo, PhD
The U.S. Food and Drug Administration (FDA) has cleared a Phase 2 clinical trial testing ARCT-032, an inhaled therapy candidate,…
A report described episodes of skin rash associated with joint pain and inflammation, known as dermatitis-arthritis syndrome, in four females…
A researcher at the University of California, Los Angeles (UCLA) has been awarded the Elizabeth Nash Postdoctoral Fellowship to…
Treatment with Trikafta (elexacaftor/tezacaftor/ivacaftor) may ease anxiety and depression symptoms in adults with cystic fibrosis (CF), a study…
Most infants with cystic fibrosis (CF) must be fed fortified milk, that is, breast milk, formula, or a combination…
About one-quarter of men with cystic fibrosis (CF) have low testosterone levels, according to a new study that sought…
Treatment with Kalydeco (ivacaftor) for almost eight years consistently improved lung function and reduced mortality in people with…
In a real-world study involving children with cystic fibrosis (CF) in Italy, …
Danish children with cystic fibrosis (CF) born between 2000 and 2022 showed noticeable gains in growth during their first…